Arizona Isotope Science Research
Arizona Isotope Science Research: Specializing in the production of medical-grade isotopes for disease imaging and treatment.
Founded
2017Arizona Isotope Science Research: Specializing in the production of medical-grade isotopes for disease imaging and treatment.
Arizona Isotope Science Research (AZI) specializes in the development and production of medical-grade isotopes for disease imaging and treatment. The company focuses on improving disease diagnostics and therapeutic interventions by manufacturing a broad range of high-quality radionuclides. AZI serves the medical community, particularly in nuclear medicine, by providing essential isotopes that enhance the accuracy of disease imaging and the efficacy of treatments targeting diseased or infected cells.
AZI has made significant strides in the field of radiopharmaceuticals, contributing to advancements in medical imaging and targeted therapies. The company's high standards in isotope production have positioned it as a key player in the medical isotope market, impacting patient care and treatment outcomes positively. Through continuous innovation and dedication to quality, AZI supports the medical community in delivering better diagnostic and therapeutic solutions.
Companies similar to Arizona Isotope Science Research include Alpha Source, NorthStar Medical Radioisotopes, Northwest Medical Isotopes and Vivos.
Arizona Isotope Science Research was founded in 2017.
Arizona Isotope Science Research's headquarters is located in Bunker Hill, IN, US.
Arizona Isotope Science Research's most recent funding round was for $58M (USD) in May 2022.
As of May 1, 2022, Arizona Isotope Science Research has disclosed funding of $113.6M (USD). Undisclosed round amounts are excluded.
Arizona Isotope Science Research has 30 employees as of Feb 5, 2024.
Vivos
radiogel.com
